Massachusetts non-compete enforcement and earn-out exposure
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
"An LOI is permission to look under the hood. Nothing more."
Andover sits in the Merrimack Valley corridor north of Boston, an area with deep roots in manufacturing, defense contracting, and life sciences. Business exits here frequently involve companies that have grown in Boston's innovation ecosystem but operate from the lower-cost suburbs. Whether the transaction is a biotech asset sale, a defense subcontractor disposition, or a manufacturing company succession plan, the legal work requires attention to Massachusetts-specific regulatory requirements and the deal structures common in the Greater Boston M&A market. Our managing partner handles every engagement directly, from initial exit planning through closing.
Share the basics. Alex reviews every inquiry personally.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Alex Lubyansky handles business exit & sell-side law work for buyers and sellers in Andover and across the country. Here is what that looks like:
We work best with people who know what they want and are ready to move:
Tell us what you are working on. We respond within one business day.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
A structured, methodical approach to business exit & sell-side law
We assess your corporate records, contracts, and legal standing to identify issues that could reduce your sale price or delay closing, and help you fix them before going to market.
We work with you and your advisors to define your priorities, whether that is maximizing cash at close, minimizing post-closing risk, retaining key terms, or achieving a clean break.
We analyze incoming offers and negotiate letter of intent terms that set you up for a successful transaction, including purchase price structure, exclusivity, and closing conditions.
Managing Partner Alex Lubyansky personally negotiates the definitive purchase agreement, fighting for seller-favorable terms on reps and warranties, indemnification, escrow, and closing mechanics.
We manage the closing process, coordinate with all parties, and handle transition services agreements and non-compete terms so you can exit on your terms.
We don't take every matter. Here is what happens when you reach out.
Alex reviews your transaction details personally. No intake coordinators, no junior associates screening your submission.
We evaluate whether your deal aligns with our practice. Not every matter is a fit, and we will tell you directly if it is not.
If there is alignment, Alex schedules a direct call to discuss your transaction, timeline, and objectives.
Before any work begins, you receive a written engagement letter with defined scope, timeline, and fee structure. No surprises.
Alex Lubyansky handles every business exit & sell-side law engagement personally.
15+ years of M&A experience. Nationwide. One attorney on every deal.
We review every transaction inquiry within one business day.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Use these before you call any firm, including ours.
At many firms, a partner sells the work and a junior associate does it. Ask for the name of the attorney who will draft and negotiate your documents.
Volume indicates current, active deal experience, not just credentials from years ago.
A $500K SBA acquisition and a $50M PE deal require different skill sets. Make sure the attorney has handled transactions similar to yours.
M&A transactions require a team. Your attorney should work with your other advisors, not in a silo.
Reps, warranties, and indemnification claims surface months after closing. Ask whether the firm handles post-closing litigation or refers it out.
Ask how the engagement is scoped, what is included, and what factors drive cost increases. Defined scope with a retainer gives the clearest cost picture.
Common questions from Andover clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsSubmit transaction details and Alex will respond directly.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
The Merrimack Valley, anchored by Andover, North Andover, and the surrounding communities along the I-93 and I-495 corridors, hosts a mix of legacy manufacturing businesses, defense electronics firms (Raytheon's presence in Andover has been a major anchor), biotech and life sciences companies, and professional services firms that serve the Greater Boston market. Business exits in this corridor often involve second-generation or third-generation family-owned manufacturers selling to PE-backed platform companies or strategic acquirers. The defense sector generates sell-side opportunities when contract cycles shift or when founders of small defense subcontractors reach retirement. Massachusetts imposes a 5% flat income tax plus a 12% short-term capital gains tax (for assets held less than one year), making the tax structuring of exits particularly important for sellers in this state.
Multi-generational manufacturing companies in the Merrimack Valley frequently face succession challenges when the next generation does not want to continue the business. These exits involve equipment appraisal, real property valuation (many manufacturers own their facilities), environmental Phase I and Phase II assessments, customer contract transferability, and workforce transition planning. Massachusetts environmental regulations (MGL Chapter 21E) impose liability on property owners for pre-existing contamination, making environmental due diligence essential for any deal involving owned real estate.
Small and mid-size defense subcontractors in the Andover area, often supporting Raytheon and other prime contractors, face exit considerations that include government contract novation requirements, ITAR compliance for controlled technical data, facility security clearance transfers, and the valuation of contract backlog. The timing of an exit relative to contract recompete cycles significantly affects deal value, and the purchase agreement must address transition of classified work.
Life sciences companies along the I-495 corridor may exit through asset sales of specific product lines, IP portfolios, or clinical-stage programs rather than whole-company transactions. These deals involve patent and trade secret assignment, FDA regulatory file transfers, license agreement novation, and representations regarding clinical data integrity. Massachusetts has strong trade secret protections under its Uniform Trade Secrets Act, and the state's non-compete reform (effective October 2018) limits non-competes to 12 months.
The Merrimack Valley corridor produces a steady flow of business exits driven by generational succession in manufacturing, defense contract cycle transitions, and life sciences portfolio transactions. Massachusetts's tax environment, including the relatively new millionaire surtax, makes exit planning and deal structuring particularly consequential for sellers. The legal work in this market requires familiarity with defense contractor regulatory requirements, Massachusetts environmental liability law, and the deal dynamics of a market where PE-backed consolidation strategies are actively targeting suburban Boston businesses.
Local Market Context
Boston-Cambridge-Newton, MA-NH MSA · MSA population 4.9M
MSA Population (2024)
4.9M
U.S. Census Bureau
Top Industry Concentration
Boston is one of the two leading life sciences and biotechnology M&A markets in the United States, alongside the San Francisco Bay Area. The Kendall Square Cambridge corridor is among the world's densest concentrations of biotech and pharmaceutical R&D. Large pharma buyers regularly acquire Boston-area biotech companies in strategic platform acquisitions. Higher education and financial services add additional M&A dimensions to the market.
Logan International Airport serves the metro with significant international connectivity. The Port of Boston handles breakbulk and specialty cargo. The MBTA regional rail serves the dense professional services workforce.
Recent Andover Deal Signal (2024-2025)
Biotech M&A in the Boston-Cambridge corridor remained highly active through 2024, with multiple large-cap pharma buyers completing acquisitions of clinical-stage companies valued between $1 billion and $10 billion. Novo Nordisk's acquisition of Cardior Pharmaceuticals and Eli Lilly's continued platform acquisitions exemplified the pattern.
Source (accessed 2026-04-27)
Massachusetts Securities Division is active in enforcement. Cambridge and Boston impose no unusual M&A-specific local rules, but Massachusetts has a non-compete statute that affects deal structure for talent-dependent transactions.
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.
Massachusetts Bar Association. Voluntary bar. The Massachusetts Supreme Judicial Court handles attorney admission separately via the Board of Bar Overseers.
Bar association websiteFederal districts: D. Mass.
Business court: Massachusetts Superior Court Business Litigation Session (established 1999) Business Litigation Session (BLS) operates in Suffolk County (Boston); handles complex business disputes. Extended to other counties on an ad hoc basis.
Massachusetts is a major M&A market for life sciences, biotechnology, technology, and financial services, with Boston and Cambridge generating significant deal activity.
Watchpoints
These are the items we see derail business exit & sell-side law transactions in the Andover market. Each one is rooted in current statutory law, recent legislative changes, or recurring patterns from the deals Alex has handled.
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
"An LOI is permission to look under the hood. Nothing more."
Massachusetts Securities Division is active in enforcement. Cambridge and Boston impose no unusual M&A-specific local rules, but Massachusetts has a non-compete statute that affects deal structure for talent-dependent transactions.
Securities regulated by Massachusetts Secretary of the Commonwealth Securities Division (sec.state.ma.us). Massachusetts has one of the more active Blue Sky enforcement environments in the U.S.; merit review authority exists for certain offerings. Non-competes are subject to Massachusetts Noncompetition Agreement Act (M.G.L. ch. 149, sec. 24L) requiring salary thresholds, garden leave pay, and prior notice.
In-depth guides to help you prepare for your transaction
Key considerations for sellers navigating the M&A process with legal representation.
Read guideA structured approach to legal, financial, and operational due diligence.
Read guideUnderstanding the binding and non-binding elements of each document.
Read guideCommon deal-killers and how experienced counsel helps prevent them.
Read guideWhat buyers should look for in a Franchise Disclosure Document.
Read guideUse these tools to prepare for your transaction. Professional analysis at your fingertips.
Acquisition Stars represents clients across Massachusetts and nationwide. Alex Lubyansky handles every engagement personally.
Don't see your city? View all Business Exit Attorney service areas or contact us directly.
"Every closing is proof that taking risks and building something matters."
15+ years of M&A and securities transaction experience Senior counsel on every engagement Admitted in Michigan, practicing nationwide
Reviewed by Alex Lubyansky on . Read full bio
Alex Lubyansky handles every engagement personally. Tell us about your transaction and we will let you know if there is a fit.
Tell us about your deal. We review every submission and respond within one business day.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
One attorney on every deal. Nationwide. 15+ years of M&A experience.